concept

SS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

162Connections

30Hypotheses

1Analyses

1Outgoing

50Incoming

3Experiments

1Debates

Summary

SS is a concept in neurodegeneration research. Key relationships include: implicated in, contributes to, causes. Connected to 162 entities in the SciDEX knowledge graph.

View on Wiki →

AI-generated illustration

Regenerate portrait ↻

💡 Concept Info

Name	SS
Key Genes/Proteins	A2M, ABCA1, ABCB1, ABCG1, ACTB, AGER
Linked Hypotheses	17 hypotheses

Wiki Pages (20)

Knowledge base pages for this entity

Pathway Diagram

graph TD
    SS["SS"]
    SS -->|"causes"| SALIVARY_GLAND["SALIVARY_GLAND"]
    T_CELL["T_CELL"] -->|"contributes to"| SS
    B_CELL["B_CELL"] -->|"contributes to"| SS
    IFN_PATHWAY["IFN_PATHWAY"] -->|"contributes to"| SS
    PI3K_AKT_MTOR["PI3K_AKT_MTOR"] -->|"contributes to"| SS
    MAP1B["MAP1B"] -->|"implicated in"| SS
    MAP2["MAP2"] -->|"implicated in"| SS
    MAP6["MAP6"] -->|"implicated in"| SS
    GLUT4["GLUT4"] -->|"implicated in"| SS
    PPAR["PPAR"] -->|"implicated in"| SS
    RAB7A["RAB7A"] -->|"implicated in"| SS

Outgoing (1)

Target	Relation	Type	Str
SALIVARY_GLAND	causes	cell_type	0.72

Incoming (161)

Source	Relation	Type	Str
PI3K_AKT_MTOR	contributes_to	pathway	0.64
T_CELL	contributes_to	cell_type	0.64
B_CELL	contributes_to	cell_type	0.64
IFN_PATHWAY	contributes_to	pathway	0.64
GSS	implicated_in	gene	0.50
CYP2E1	implicated_in	gene	0.50
IDH2	implicated_in	gene	0.50
IDH1	implicated_in	gene	0.50
HIF	implicated_in	gene	0.50
TKT	implicated_in	gene	0.50
TIGAR	implicated_in	gene	0.50
NAD	implicated_in	gene	0.50
FUBP1	implicated_in	gene	0.50
BRAF	implicated_in	gene	0.50
H3F3A	implicated_in	gene	0.50
ATRX	implicated_in	gene	0.50
CIC	implicated_in	gene	0.50
MCU	implicated_in	gene	0.50
LETM1	implicated_in	gene	0.50
P2RY12	implicated_in	gene	0.50
LC3	implicated_in	gene	0.50
APOA1	implicated_in	gene	0.50
PI3K	implicated_in	gene	0.50
MAP1LC3	implicated_in	gene	0.50
ABCG1	implicated_in	gene	0.50
LOX	implicated_in	gene	0.50
AMPK	implicated_in	gene	0.50
AKT	implicated_in	gene	0.50
ABCA1	implicated_in	gene	0.50
ULK1	implicated_in	gene	0.50
LDL	implicated_in	gene	0.50
ATG5	implicated_in	gene	0.50
IBA1	implicated_in	gene	0.50
REL	implicated_in	gene	0.50
CERS2	implicated_in	gene	0.50
DAG1	implicated_in	gene	0.50
IGF1R	implicated_in	gene	0.50
HSPG2	implicated_in	gene	0.50
BAD	implicated_in	gene	0.50
DAPK1	implicated_in	gene	0.50
PARP1	implicated_in	gene	0.50
A2M	implicated_in	gene	0.50
DHCR24	implicated_in	gene	0.50
HMGCR	implicated_in	gene	0.50
IL6	implicated_in	gene	0.50
PSEN1	implicated_in	gene	0.50
APH1B	implicated_in	gene	0.50
APP	implicated_in	gene	0.50
PEN2	implicated_in	gene	0.50
MAPT	implicated_in	gene	0.50

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen	0.990	neurodegeneration	TREM2 in Alzheimer's Disease: Mechanisms
Closed-loop transcranial focused ultrasound targeting EC-II	0.948	Alzheimer's disease	Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting EC-II	0.922	Alzheimer's disease	Circuit-level neural dynamics in neurode
CYP46A1 Overexpression Gene Therapy	0.919	neurodegeneration	Lipid raft composition changes in synapt
TREM2-ASM Crosstalk in Microglial Lysosomal Senescence	0.910	neurodegeneration	Gene expression changes in aging mouse b

TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene	0.907	neurodegeneration	Gene expression changes in aging mouse b
Closed-loop focused ultrasound targeting EC-II SST interneur	0.900	Alzheimer's disease	Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II SST interneurons to block t	0.896	Alzheimer's disease	Circuit-level neural dynamics in neurode
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener	0.892	neurodegeneration	Gene expression changes in aging mouse b
TREM2-APOE Axis Dissociation for Selective DAM Activation	0.886	neurodegeneration	TREM2 agonism vs antagonism in DAM micro
Optimized Temporal Window for Metabolic Boosting Therapy Det	0.879	neurodegeneration	How do different microglial subtypes (DA
Closed-loop tACS targeting EC-II PV interneurons to suppress	0.857	Alzheimer's disease	Circuit-level neural dynamics in neurode
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro	0.847	Alzheimer's Disease	Cell type vulnerability in Alzheimers Di
Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte	0.839	neurodegeneration	View
Real-time gamma-guided transcranial focused ultrasound targe	0.827	Alzheimer's disease	Circuit-level neural dynamics in neurode
SIRT1 Activation Couples Mitochondrial Biogenesis to Ferropt	0.824	neurodegeneration	View
ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drive	0.801	Alzheimer's Disease	Cell type vulnerability in Alzheimers Di
40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Pri	0.801	Alzheimer's Disease	Cell type vulnerability in Alzheimers Di
Excitatory Neuron Synaptic Dysfunction and Mitochondrial Str	0.790	neurodegeneration	Cell type vulnerability debate in Alzhei
Closed-loop tACS targeting entorhinal cortex layer II SST in	0.784	Alzheimer's disease	Circuit-level neural dynamics in neurode
LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferrop	0.779	Alzheimer's Disease	Cell type vulnerability in Alzheimers Di
ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligo	0.779	Alzheimer's Disease	Cell type vulnerability in Alzheimers Di
TBK1 Loss Locks Microglia in an Aged/Senescent Transcription	0.776	ALS	What are the mechanisms by which microgl
LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Sub	0.776	Alzheimer's Disease	Cell type vulnerability in Alzheimers Di
Alpha-gamma cross-frequency coupling enhancement to restore	0.775	Alzheimer's disease	Circuit-level neural dynamics in neurode
LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vul	0.770	Alzheimer's Disease	Cell type vulnerability in Alzheimers Di
Chromatin Accessibility Restoration via BRD4 Modulation	0.768	neurodegeneration	Epigenetic reprogramming in aging neuron
Multi-Modal Stress Response Harmonization	0.756	neurodegeneration	Digital biomarkers and AI-driven early d
Selective blockade of classical-pathway activation downstrea	0.750	neurodegeneration	Does C1q function differ based on subcel
TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming	0.748	neurodegeneration	Gene expression changes in aging mouse b

Mentioning Analyses (1)

Scientific analyses that reference this entity

Are interneuron oscillation deficits compensatory responses or primary pathologi

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.747

Experiments (3)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Plant-based dietary patterns and Alzheimer's disease risk in multiethn	clinical	Alzheimer's disease and relate	0.950	0.00	human patients	proposed	N/A
Metal Ion Homeostasis Dysregulation in Alzheimer's Disease	validation	Alzheimer's Disease	0.400	0.50	human	proposed	$2,730,000
Wilson Disease Neurodegeneration: Mechanism and Therapeutic Response	clinical	Neurodegeneration	0.400	0.50	human	proposed	$7,500,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704]	Zhang T, Xu D, Trefts E, Lv M, Inuzuka H	Science	2023	1
TREM2, microglia, and Alzheimer's disease. [PMID:33516818]	Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang	Mech Ageing Dev	2021	1
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797]	Zhou Y, Song WM, Andhey PS, Swain A, Lev	Nat Med	2020	1
Complement and microglia mediate early synapse loss in Alzheimer mouse models. [PMID:27033548]	Hong S, Beja-Glasser VF, Nfonoyim BM, Fr	Science	2016	1
Potential Biological Processes Related to Brain SLC13A5 Across the Lifespan: Wei [PMID:41750164]	Ferreira BK, Schuck PF, Ferreira GC, Fre	Brain sciences	2026	0
How cytochrome P450 enzymes in humans are involved in Parkinson's disease: a lit [PMID:41730497]	Ren B, Yan H, Han C, Sun S, Wang D, Xu Y	Neuroscience	2026	0
Dysregulated Cholesterol Clearance via CYP46A1 Contributes to Cerebellar Sterol [PMID:41828569]	Tapia PJ, Rivera BI, Espinoza CS, Stolze	International journal of molec	2026	0
Efavirenz treatment improves retinal vaso-obliteration and pathological neovascu [PMID:41810243]	Bailey B, Rudd Zhong Manis J, Seth G, Ra	Frontiers in medicine	2026	0
Radiosynthesis and Evaluation of 18F‑Labeled Deuterated Radioligand for Positron [PMID:41704371]	Li Y, Song Z, Shi H, Zhao T, Chen J, Zho	ACS medicinal chemistry letter	2026	0
Streptozotocin and L-Buthionine-Sulfoximine Decrease Neuron Membrane Lipid Packi [PMID:40439741]	Martins YA, Cardinali CAEF, Costa AP, To	Neurotoxicity research	2025	0
Treatment with efavirenz extends survival in a Creutzfeldt-Jakob disease model b [PMID:40540390]	["Ali T", "Cashion J", "Hannaoui S", "Ah	JCI insight	2025	0
The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkins [PMID:39964974]	Dai L, Wang J, Meng L, Zhang X, Xiao T,	PLoS biology	2025	0
Microglia, Trem2, and Neurodegeneration. [PMID:38769824]	Shi Q, Gutierrez RA, Bhat MA	Neuroscientist	2025	0
Microglia, Trem2, and Neurodegeneration. [PMID:38769824]	Shi Q, Gutierrez RA, Bhat MA	The Neuroscientist : a review	2025	0
Sterol imbalances and cholesterol-24-hydroxylase dysregulation is linked to the [PMID:40045480]	Griffiths L, Hawkins K, Yutuc E, Angelin	Brain pathology (Zurich, Switz	2025	0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025	0
Astrocyte-neuron combined targeting for CYP46A1 gene therapy in Huntington's dis [PMID:40859407]	Parsai LH, Chali F, Subashi E, Zeitouny	Acta neuropathologica communic	2025	0
Overexpression of cholesterol 24-hydroxylase CYP46A1 attenuates retinal dysfunct [PMID:40975483]	Long Z, Zhang J, Feng J, He T	Experimental eye research	2025	0
Cholesterol metabolic reprogramming mediates microglia-induced chronic neuroinfl [PMID:40987840]	Zhao Q, Li J, Feng J, Wang X, Liu Y, Wan	Nature metabolism	2025	0
Elevated 24-hydroxycholesterol levels counteract okadaic acid-induced tau hyperp [PMID:40653030]	Giannelli S, Eroli F, Loera-Valencia R,	Neurobiology of disease	2025	0

Debates (1)

Multi-agent debates referencing this entity

The debate raised whether SST/PV interneuron dysfunction represents adaptive com

closed · Rounds: 4 · Score: 0.76 · 2026-04-16

Related Research

Hypotheses and analyses mentioning SS in their description or question text

TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegeneration

Score: 0.907 · neurodegeneration · 2026-04-12

## Mechanistic Overview TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegeneration starts from the claim that mo

Closed-loop focused ultrasound targeting EC-II SST interneurons to restore gamma

Score: 0.900 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop focused ultrasound targeting EC-II SST interneurons to restore gamma gating and bloc

Closed-loop tACS targeting EC-II SST interneurons to block tau propagation and r

Score: 0.896 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop tACS targeting EC-II SST interneurons to block tau propagation and restore perforant

TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration

Score: 0.892 · neurodegeneration · 2026-04-07

## Mechanistic Overview TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration starts from the claim that mod

TREM2-APOE Axis Dissociation for Selective DAM Activation

Score: 0.886 · neurodegeneration · 2026-04-16

## Mechanistic Overview TREM2-APOE Axis Dissociation for Selective DAM Activation starts from the claim that modulating

Optimized Temporal Window for Metabolic Boosting Therapy Determines Success of M

Score: 0.879 · neurodegeneration · 2026-04-16

## Mechanistic Overview Optimized Temporal Window for Metabolic Boosting Therapy Determines Success of Microglial State

Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and bl

Score: 0.857 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and block tau propagat

ACSL4-Driven Ferroptotic Priming in Disease-Associated Microglia

Score: 0.847 · Alzheimer's Disease · 2026-04-02

## Mechanistic Overview ACSL4-Driven Ferroptotic Priming in Disease-Associated Microglia starts from the claim that modu

Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte Secretome

Score: 0.839 · neurodegeneration · 2026-04-17

## Mechanistic Overview Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte Secretome starts from the claim tha

Real-time gamma-guided transcranial focused ultrasound targeting EC-II SST inter

Score: 0.827 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Real-time gamma-guided transcranial focused ultrasound targeting EC-II SST interneurons to resto

SIRT1 Activation Couples Mitochondrial Biogenesis to Ferroptosis Suppression via

Score: 0.824 · neurodegeneration · 2026-04-17

## Mechanistic Overview SIRT1 Activation Couples Mitochondrial Biogenesis to Ferroptosis Suppression via PGC1alpha-Depen

ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matter Degen

Score: 0.801 · Alzheimer's Disease · 2026-04-05

## Mechanistic Overview ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matter Degeneration in Alzhe

40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Selectively

Score: 0.801 · Alzheimer's Disease · 2026-04-05

## Mechanistic Overview 40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Selectively Eliminate Diseas

Excitatory Neuron Synaptic Dysfunction and Mitochondrial Stress via MAPT (tau)

Score: 0.790 · neurodegeneration · 2026-04-22

## Mechanistic Overview Excitatory Neuron Synaptic Dysfunction and Mitochondrial Stress via MAPT (tau) starts from the c

Closed-loop tACS targeting entorhinal cortex layer II SST interneurons to activa

Score: 0.784 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop tACS targeting entorhinal cortex layer II SST interneurons to activate AMPK-autophag

SS

Understanding Entity Pages

Summary

Wiki Pages (20)

Subacute Sclerosing Panencephalitis (SSPE)

ADSS1 — Adenylosuccinate Synthetase 1

GSS Gene (Glutathione Synthetase)

SST Protein — Somatostatin

Section 174: Oligonucleotide Therapies (ASO/SSO) in CBS/PSP

CASS2 — CASP2 and RIPK1 Domain Containing Adaptor

CTSS — Cathepsin S

Gerstmann-Sträussler-Scheinker Syndrome (GSS)

SSVEP Brain-Computer Interface

SSBP1 Gene

SSRI Antidepressants

Rifaximin SSD in Dementia Trial (RIDE)

ADSS2 — Adenylosuccinate Synthetase 2

Cortical SST Detector Cells

Somatostatin-Positive (SST+) Interneurons

SST Gene

Glutathione Synthetase (GSS)

Somatostatin (SST)

Woodhouse-Sakati Syndrome (WSS)

SSBP1 Protein